Watson Pharmaceuticals Acquires Strides Arcolab’s Generics Business in Australia and Southeast Asia for $393 Million

Watson Pharmaceuticals (Parsippany, NJ) and Strides Arcolab (Bangalore, India) say that Watson has acquired Ascent Pharmahealth (Melbourne), the generic pharmaceutical business of Strides Arcolab in Australia and Southeast Asia for A$375 million ($393 million) in cash. Ascent is one of the top five generic pharmaceutical companies in Australia and is present across several countries in Southeast Asia, including Singapore where it is the leading generic pharmaceutical company. With the acquisition, Watson becomes the fifth largest generic pharma company in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers